mortality/aging
• newborn homozygotes are externally normal but gradually fail to thrive and die within 6-14 hrs after birth most likely due to respiratory failure combined with an inability to suckle
|
behavior/neurological
• newborn homozygotes lack milk in their stomachs
|
• newborn homozygotes are unable to suckle
|
• newborn homozygotes are hyporesponsive to mild tactile stimuli such as gentle touch
• when picked up and nipped by their tail, newborn homozygotes display only a weak (8/10) or no (2/10) tail pinching response
|
• upon mild tactile stimulation, newborn homozygotes assume an abnormal body posture with dropping forelimbs
|
bradykinesia
(
J:86624
)
• newborn homozygotes display only weak or no spontaneous motor activity
|
respiratory system
• newborn homozygotes display a severe breathing irregularity
• however, no histologic abnormalities of the airways or lungs are observed and the musculo-skeletal system appears unaffected
|
• newborn homozygotes show a severe depression of respiratory frequencies to only 16% of those in wild-type pups, as shown by whole-body plethysmography
• although durations of single breaths are only marginally longer, expiratory intervals are significantly prolonged as shown by a 4-fold increase of the coefficient of variation relative to that in control littermates
|
• newborn homozygotes exhibit long periods of apnea interrupted by gasp-like inspirations
|
• newborn homozygotes exhibit long periods of apnea interrupted by gasp-like inspirations
|
growth/size/body
• newborn homozygotes weigh ~15% less than control littermates
|
homeostasis/metabolism
dehydration
(
J:86624
)
muscle
nervous system
N |
• newborn homozygotes display normal brain stem and spinal cord histology
• no major adaptive changes in synapse biochemistry or differences in synaptic protein expression are observed in the CNS
• the density and morphology of glial cells appear unaffected
|
• P2 membrane fractions from newborn homozygotes show a >70% and >80% reduction of [3H]glycine uptake in frontal brain and CNS caudal regions, respectively, relative to wild-type controls
• increased accumulation of extracellular glycine leads to a sustained activation of inhibitory glycine receptors and results in suppression of the respiratory network activity
|
• in vitro analysis of inspiratory activity in mutant brain stem slices indicates prolonged periods of inactivity and a significantly reduced burst frequency with variable interburst intervals relative to the regular rhythmic bursting observed in control slices
• application of the glycine receptor antagonist strychnine (2 uM) increases burst activity by 3.6-fold leading to a frequency comparable to that seen under control conditions in wild-type mice; however, the activity of mutant slices is consistently more irregular than that of wild-type preparations
• the coefficient of variation of the interburst interval is significantly higher in mutant slices and is only partially improved upon strychnine application
• however, no differences in rise time and burst duration are observed between brain stem slices from wild-type and mutant mice
• application of the GABAA receptor antagonist bicuculline (1-2 uM) fails to normalize the rhythmic burst patterns observed in mutant slices
• application of the NMDA receptor blockers MK-801 (10 uM) and AP-5 (100 uM) fails to restore a regular respiratory rhythm in mutant slices
|
• whole-cell recordings from hypoglossal motoneurons at a holding potential of -70 mV indicate that during periods without obvious IPSCs, the average noise values recorded from mutant neurons are significantly higher than those observed in wild-type cells
• the average interval of IPSCs identified in mutant hypoglossal motoneurons is significantly lower than in wild-type cells, whereas the average IPSC amplitude is not significantly smaller than that in wild-type cells
• the IPSC decay time is significantly longer in mutant neurons relative to wild-type cells
• application of strychnine decreases the steady-state holding current in mutant hypoglossal motoneurons and reduces synaptic noise to wild-type levels
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
glycine encephalopathy | DOID:9268 |
OMIM:PS605899 |
J:86624 |